Results 31 to 40 of about 909,284 (217)

Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes

Bleeding, Thrombosis and Vascular Biology
We report three unrelated cases of Hermansky-Pudlak (HP) characterized by novel mutations in HPS3 (compound heterozygosity for c.1457G>A and c.1813G>T), HPS6 (homozygous c.210_211insGGGCC), and HPS8 (homozygous c.299dupC in BLOC1S3) genes.
Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman   +4 more
doaj   +1 more source

A message of science, peace and gratitude

Bleeding, Thrombosis and Vascular Biology
As we approach Christmas and the New Year 2026 - which will be the fifth for our journal - we want to extend our heartfelt gratitude to our Section Editors, to every eminent Colleague of the Editorial Board, to the Authors, reviewers, readers of the ...
Giovanni de Gaetano, Chiara Cerletti
doaj   +1 more source

A Pharmacist-Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization among Patients with Sickle Cell Disease

Advances in Hematology
Sickle cell disease (SCD) is a common genetic disorder with potentially serious sequelae that can be effectively treated with hydroxyurea. Despite its favorable benefit-risk profile, hydroxyurea uptake in patients with SCD is low.
Cameron Roessner, Trudy Sale, Kelsey Uminski, Dawn Goodyear, Natalia Rydz   +4 more
doaj   +1 more source

At the age of three

Bleeding, Thrombosis and Vascular Biology
At the age of three, a little boy is able to undress and is starting to dress independently, can eat using a spoon and fork, knows how to hold a pencil correctly, and enjoys drawing vertical, horizontal, and curved lines with pencils and colored crayons.
Giovanni de Gaetano, Chiara Cerletti
doaj   +1 more source

CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury - a nested, randomised, placebo-controlled trial [PDF]

, 2012
Background: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the risk of death in patients with traumatic bleeding, with no apparent increase in vascular occlusive events.
Wardlaw, J, Prieto-merino, David, Al-Shahi Salman, R, P Sandercock, Perel, P, R Al-Shahi Salman, T Kawahara, Prieto-Merino, D, Sandercock, P, Roberts, Ian, Perel, Pablo, Kawahara, T, P Perel, Shakur-still, Haleema, H Shakur, Salman, RAS, D Prieto-Merino, J Wardlaw, Morris, Z, Shakur, H, Z Morris, I Roberts, Roberts, I   +22 more
core   +1 more source

In this issue

Bleeding, Thrombosis and Vascular Biology
The second issue of Bleeding, Thrombosis and Vascular Biology (BTVB) 2026 opens with an editorial, that is linked to one of the first articles of our journal, published in the first issue of 2022 and concerns the use of statistics in biomedical research.
Giovanni de Gaetano, Chiara Cerletti
doaj   +1 more source

Assesment of Upper Gastrointestinal Bleeding in the Pediatric Emergency Department [PDF]

, 2023
Introduction:Upper gastrointestinal bleeding is an important emergency problem that can occur at any age in childhood and requires urgent treatment for the underlying cause.
Betül Öztürk, Aysun Tekeli, KARACAN, CAN DEMİR, ŞAHİN, GÜLSEREN, Ayla Akca Çağlar, Nilden Tuygun, AKCA ÇAĞLAR, AYLA, BODUR, İLKNUR, Gülseren Şahin, ÖZBAY HOŞNUT, FERDA, TUYGUN, NİLDEN, Ferda Özbay Hoşnut, İlknur Bodur, Can Demir Karacan, TEKELİ, AYSUN, ÖZTÜRK, BETÜL   +15 more
core   +1 more source

The Bleeding Disorders Research Collaborative

Blood Vessels, Thrombosis & Hemostasis
: The Bleeding Disorders Research Collaborative (BDRC) aims to advance an accessible standard of care and quality of life for all people living with inheritable bleeding disorders.
Leonard A. Valentino, Maria E. Santaella, Michelle L. Witkop, Raymond W. Stanhope, Sammie Valadez, Samantha A. Carlson, Halli Benasutti, Donna DiMichele, Michael Recht   +8 more
doaj   +1 more source

Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia A

BMJ Open, 2021
Introduction Haemophilia A is a rare bleeding disorder caused by defects in coagulation factor VIII (FVIII). Damoctocog alfa pegol (BAY 94–9027, Jivi, Bayer, Germany) is a site-specifically PEGylated, extended-half-life, recombinant FVIII, approved for ...
Johannes Oldenburg, Karina Meijer, Martin Sanabria, María Teresa Álvarez Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Sabine Friedl, M T Reding   +8 more
doaj   +1 more source

A Fourfold Increase of Oesophageal Variceal Bleeding in Cirrhotic Patients with a History of Oesophageal Variceal Bleeding [PDF]

, 2016
INTRODUCTION: There is no large, recent, population-based data for evaluating the predictors of oesophageal variceal bleeding (OVB) among cirrhotic patients.
Tsung-Hsing Hung; Chih-Wei Tseng; Chih-Chun Tsai; Chorng-Jang Lay; Chen-Chi Tsai, Hung, T. H.; Tseng, C. W.; Tsai, C. C.; Lay, C. J.; Tsai, C. C.   +1 more
core   +1 more source